India’s medical tourism market is valued at USD 20.4 billion in 2026 and is projected to reach USD 65.1 billion by 2036, expanding at a 12.3% CAGR over the forecast period. As per Future Market Insights, market expansion is being shaped by India’s cost competitiveness in advanced medical procedures, growing international demand for high-quality yet affordable healthcare, and the rising global acceptance of cross-border treatment for elective and complex procedures. Medical travel to India is no longer limited to price-sensitive patients from neighboring countries, with demand expanding across Africa, the Middle East, Southeast Asia, and selected developed markets as hospital accreditation standards and clinical outcomes gain wider recognition. The scale of inbound medical travel is reflected in official government data. As stated by Gajendra Singh Shekhawat, Union Minister for Tourism and Culture, “India recorded 1,31,856 foreign tourist arrivals (FTAs) for medical purposes from January to April 2025, accounting for approximately 4.1% of total FTAs during the period,” underscoring the growing contribution of medical travel to overall inbound tourism volumes.
Patient inflows between 2025 and 2026 reflect a strong rebound in cross-border medical travel, with international patients demonstrating higher willingness to opt for specialized procedures such as cardiac surgery, orthopedics, oncology treatments, fertility services, and cosmetic surgery. Demand is increasingly shaped by treatment-led travel themes such as wellness-integrated recovery programs, minimally invasive surgeries, and bundled care pathways that combine procedures with post-operative rehabilitation. Hospital groups and medical travel facilitators are expanding end-to-end care models that integrate clinical treatment, accommodation, transfers, and post-treatment follow-up to capture higher per-patient value. Healthcare providers and destination health authorities are intensifying international referral partnerships and overseas outreach programs to secure a larger share of global medical traveler flows.
The growing preference for comprehensive care packages and shorter recovery timelines is strengthening patient volumes, particularly among middle-income international patients seeking faster access to procedures and personalized care pathways. Digital-first discovery, tele-consultations, and online hospital selection platforms are reshaping how international patients evaluate treatment options, increasing conversion rates for pre-booked procedures and coordinated travel. Policy support measures are also contributing to demand-side momentum through medical visa facilitation, hospital accreditation frameworks, and cross-border patient care protocols. Future Market Insights notes that medical tourism demand in India is likely to remain structurally strong, supported by expanding private healthcare capacity, continued investment in tertiary and quaternary care infrastructure, and deeper integration of India into global healthcare referral networks through 2036.
Future Market Insights projects India’s medical tourism market to grow at a 12.3% CAGR from 2026 to 2036, expanding from USD 20.4 billion in 2026 to USD 65.1 billion by 2036.
FMI Research Approach: FMI proprietary forecasting model based on bottom-up estimation of international patient spending, tracking inbound medical travel volumes, and demand modeling linked to procedure mix, hospital capacity expansion, and cross-border healthcare affordability dynamics.
FMI analysts perceive medical tourism in India evolving from cost-driven treatment travel toward more structured, service-integrated healthcare journeys. Growth is supported by rising inflows from Africa, the Middle East, and Southeast Asia, expanding private hospital networks, and increasing preference for bundled care pathways covering treatment, recovery, and follow-up services.
FMI Research Approach: Assessment of patient origin mix by region, evaluation of procedure complexity and length of stay, and analysis of treatment pathways, post-operative care models, and per-patient spending patterns across major medical specialties.
The Middle East, Africa, and South Asia account for the largest share of inbound medical tourism spend in India, supported by geographic proximity, referral networks, established patient flows, and strong demand for tertiary and quaternary care services.
FMI Research Approach: FMI source-region demand assessment based on inbound patient flows, procedure-level demand patterns, hospital intake data, and referral channel mapping across key origin markets.
India’s medical tourism market is projected to reach USD 65.1 billion by 2036.
FMI Research Approach: FMI long-term forecast by source region, procedure category, and care delivery model, incorporating assumptions around hospital capacity growth, international patient recovery cycles, and long-term penetration of cross-border healthcare services.
The India medical tourism market comprises cross-border travel to India by international patients seeking medical, surgical, dental, fertility, cosmetic, and wellness-related treatments, covering spending on clinical procedures, hospital services, accommodation, and treatment-linked travel support.
FMI Research Approach: FMI market taxonomy and inclusion-exclusion framework covering inpatient and outpatient procedures, elective and complex treatments, and bundled care pathways, while excluding domestic healthcare utilization and inbound leisure tourism unrelated to medical treatment.
Globally unique trends shaping the market include rising acceptance of cross-border treatment for elective procedures, growth in bundled care and recovery packages, increasing use of tele-consultations for pre- and post-treatment coordination, and expanding hospital accreditation to attract international patients.
FMI Research Approach: Analysis of procedure mix trends, care pathway evolution, hospital accreditation coverage, digital health adoption in international patient management, and source-region diversification patterns.
| Metric | Details |
|---|---|
| Industry Size (2026) | USD 20.4 Billion |
| Industry Value (2036) | USD 65.1 Billion |
| CAGR (2026-2036) | 12.3% |
Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research.
International patients are increasingly viewing India as a planned treatment destination rather than a last-resort option driven only by cost considerations. Future Market Insights notes that patients now place greater emphasis on predictable care pathways, coordinated hospital engagement before travel, and access to multi-specialty centers capable of managing complex procedures within defined treatment windows. Earlier waves of medical travel to India were concentrated among regional patients seeking basic interventions, which limited the scale and diversity of inflows. This is changing as India attracts patients from Africa, the Middle East, and parts of Southeast Asia for tertiary and quaternary care, supported by improving clinical outcomes and international accreditation visibility.
Healthcare provider strategies mirror this shift. Fortis Healthcare has expanded international patient programs by offering dedicated overseas patient desks, pre-arrival clinical coordination, and bundled procedure-and-recovery pathways that simplify the logistics of cross-border care. These service models reduce uncertainty around treatment planning and post-procedure recovery, enabling medical travel to align with patients’ clinical timelines and budget planning. FMI observes that hospitals institutionalizing international patient journeys through standardized service frameworks are more likely to capture sustained referral flows and repeat international demand as medical tourism matures into a structured healthcare delivery channel.
The India medical tourism market is segmented by treatment type, age group, tourist type, service provider, traveler type, demography, and booking channel, reflecting differences in clinical demand, care delivery preferences, patient profiles, and planning behavior. By treatment type, cardiovascular and orthopedic procedures represent the largest share due to high treatment value and procedure volumes. By age group, patients aged 36 to 55 years account for the largest share of inbound medical travel. By tourist type, international patients dominate total medical tourism revenues. By service provider, private hospitals lead market share due to specialized care availability. By traveler type, independent travelers account for the majority of medical travel journeys. By demography, male patients represent a slightly larger share of inbound patient volumes. By booking channel, online booking leads patient acquisition and pre-arrival coordination.
Cardiovascular treatments account for 31.6% of India’s medical tourism revenues, reflecting sustained international demand for complex cardiac procedures at competitive cost levels. Patients frequently seek bypass surgery, angioplasty, and valve replacement procedures in India, where outcomes and clinician experience are well established. Cardiac procedures carry high per-patient value, which elevates their revenue contribution compared with dental or cosmetic treatments. Treatment pathways are often bundled with diagnostics and post-operative care, increasing overall transaction size. This concentration of high-value procedures anchors cardiovascular care as the largest treatment subsegment within India’s medical tourism market.
Patients aged 36 to 55 years represent 38.9% of total medical tourism demand, driven by higher incidence of lifestyle-related conditions, orthopedic issues, and cardiac risk factors within this age cohort. This group actively seeks elective and semi-elective procedures that can be planned around work schedules and recovery timelines. Higher disposable income and insurance coverage support willingness to travel for quality care. Their procedures often involve longer hospital stays and follow-up care, increasing per-patient spending. These factors collectively position the 36 to 55 years cohort as the dominant age group within India’s inbound medical tourism flows.
International patients account for over 82.0% of total medical tourism revenues, reflecting higher per-patient spending associated with cross-border treatment journeys. In addition to clinical costs, international patients incur travel, accommodation, and bundled care expenses, which elevate transaction values. They are more likely to opt for comprehensive treatment packages covering diagnostics, procedures, and recovery. Referral networks and medical travel facilitators further concentrate demand among overseas patients seeking tertiary and quaternary care. This pattern is evident at institutions such as Sankara Nethralaya, which reports a substantial share of its patient inflows from international markets, particularly South Asia and Africa, underscoring the structural reliance of leading Indian specialty hospitals on cross-border patient volumes. The complexity and value of procedures sought by international patients reinforce their dominant revenue contribution within India’s medical tourism market. FMI notes that growing competition among destination countries for medical tourism is placing greater emphasis on consistency in care delivery across facilities, departments, and treatment categories.
Medical tourism in India is gaining momentum as international patients seek coordinated care pathways, predictable treatment timelines, and end-to-end service models rather than fragmented hospital visits. Cross-border patients increasingly value pre-arrival consultations, structured admission planning, and integrated recovery support, which simplify complex treatment journeys. Compared with earlier patterns where patients navigated hospitals independently, service-led care models now emphasize continuity across diagnosis, procedure, and post-treatment recovery. As per Future Market Insights, medical travel to India is increasingly positioned as a planned healthcare journey rather than an ad hoc response to cost differences. The growing availability of bundled care pathways reduces uncertainty for international patients and contributes to wider acceptance of India as a reliable destination for complex and elective procedures.
Care pathway integration is strengthening competitive positioning by enabling hospitals to offer coordinated treatment journeys that combine clinical care, accommodation, logistics, and post-operative follow-up within a single service framework. Leading hospital networks are extending beyond procedure delivery to manage the full patient experience, focusing on continuity of care rather than isolated treatment episodes. This strategy improves service consistency, patient confidence, and recovery outcomes across international patient programs. The impact of integrated care models is reflected in the international patient service programs operated by Apollo Hospitals, which provide dedicated global patient desks, pre-arrival coordination, and bundled treatment pathways for overseas patients. According to FMI, embedding international patient care within standardized hospital service models improves referral conversion and repeat international patient inflows by leveraging clinical credibility and institutional trust.
Rising expectations around treatment quality, safety protocols, and recovery outcomes are pushing healthcare providers to standardize clinical workflows and service delivery models for international patients. Cross-border patients increasingly compare hospitals on accreditation status, surgeon experience, infection control protocols, and post-operative care standards. Minor variations in clinical pathways can influence patient confidence and referral decisions. This focus on clinical standardization enables scalability of medical tourism programs and positions Indian providers as dependable care destinations rather than opportunistic treatment alternatives driven purely by cost considerations.
India’s medical tourism demand is expanding as international patient inflows rise and private hospital capacity deepens across key treatment hubs. While the national market grows at a 12.3% CAGR from 2026 to 2036, medical travel intensity varies by region based on hospital density, clinical specialization, international connectivity, and service ecosystem maturity. South, North, and West India form the primary demand axis, driven by multi-specialty hospital clusters, transplant programs, and tertiary care depth. East India remains comparatively smaller but is steadily scaling as healthcare infrastructure, international patient desks, and connectivity improve. FMI analysis indicates that future growth will come from broader regional diffusion of international patient programs beyond a few legacy medical hubs.
| Region-wise | CAGR (2026 to 2036) |
|---|---|
| South India | 12.8% |
| West India | 12.3% |
| North India | 12.1% |
| East India | 9.2% |
Source: FMI historical analysis and forecast data.
At a 12.8% CAGR, South India leads inbound medical tourism due to the concentration of high-volume tertiary and quaternary care centers in Chennai, Bengaluru, and Hyderabad. The region is widely recognized for cardiac sciences, organ transplants, oncology, and ophthalmology, attracting international patients seeking complex procedures at competitive costs. Strong clinical outcomes, standardized care pathways, and dedicated international patient desks support predictable treatment journeys. Air connectivity through Chennai, Bengaluru, and Hyderabad enables steady patient inflows from Southeast Asia, the Middle East, and Africa. FMI analysis indicates that South India’s leadership is sustained by clinical depth, throughput capacity, and strong specialty concentration.
Growing at a 12.3% CAGR, West India remains a major contributor to medical tourism flows, anchored by Mumbai and Pune. The region benefits from dense private hospital networks, advanced transplant programs, and well-developed cardiac and oncology centers. Mumbai’s international airport supports direct access for patients from Africa and the Middle East, while Pune contributes demand through specialized orthopedic and rehabilitation services. The surrounding ecosystem of diagnostics, hospitality, and recovery facilities enables end-to-end care pathways for international patients. FMI notes that West India’s medical tourism strength is underpinned by procedural depth, strong referral networks, and mature private healthcare infrastructure.
At a 12.1% CAGR, North India anchors high-value and complex medical tourism demand through the NCR region’s concentration of multi-specialty hospitals and centers of excellence. International patients traveling to Delhi NCR often seek oncology, neurosurgery, orthopedics, and organ transplant services, which carry higher per-patient value and longer care pathways. Strong intercontinental connectivity via Delhi International Airport reduces friction for long-haul patient travel from Africa, Central Asia, and the Middle East. The region’s ecosystem supports coordinated care models integrating diagnostics, treatment, accommodation, and follow-up. FMI notes that North India’s growth is more value-led than volume-driven, reinforcing its premium care positioning.
At a 9.2% CAGR, East India’s gradual scale-up in medical tourism is reflected in the international patient services developed by Manipal Hospitals (formerly AMRI), which operates multi-specialty facilities in Kolkata and has formal outreach programs for patients from Bangladesh and neighboring countries. The group has invested in tertiary care capabilities acrosss oncology, cardiology, and nephrology, alongside dedicated international patient coordination desks to support cross-border referrals. This illustrates how expanding private hospital capacity, accreditation coverage, and structured facilitation services in Kolkata are strengthening East India’s ability to attract international patients, even as the regional ecosystem remains less mature than established hubs in South and West India.
The competitive landscape for India’s medical tourism market is led by large, multi-specialty hospital networks that extend beyond core clinical services to support structured international patient pathways. Players such as Apollo Hospitals, Fortis Healthcare, and Medanta, the Medicity benefit from extensive hospital footprints, established physician reputations, and dedicated international patient programs. Apollo Hospitals has disclosed in its public communications that international patients form a meaningful share of its tertiary care volumes, supported by overseas referral partnerships and global patient services across its hospital network. Competitive positioning in this market is less about rapid bed capacity expansion and more about the ability to deliver coordinated treatment journeys that integrate diagnostics, procedures, recovery, and post-treatment follow-up for overseas patients.
Future Market Insights observes that competition is increasingly centered on clinical outcomes, accreditation coverage, and patient experience rather than aggressive geographic growth. Fortis Healthcare reports international patient inflows across its cardiac sciences, oncology, and orthopedics centers of excellence through structured international patient desks and pre-arrival coordination workflows highlighted in company disclosures. Medanta has similarly emphasized specialized tertiary care programs and multidisciplinary treatment pathways for international patients, reflecting how leading providers compete on clinical depth and service integration rather than pricing alone. FMI notes that long-term competitive advantage will depend on how effectively hospital networks embed international patient services into core clinical operations, positioning medical tourism as an integrated care offering rather than a peripheral service line.
Recent Developments:
The India medical tourism market captures revenue generated from cross-border travel to India for medical and healthcare services. In this assessment, the market covers commercially delivered medical treatments and care services consumed by international patients, including clinical procedures, diagnostics, inpatient and outpatient services, and treatment-linked travel arrangements. Market sizing reflects total spending by international patients on medical care in India, analyzed by treatment type, service provider, traveler type, booking channel, and region of origin, and reported in USD billion.
The scope includes medical travel to India for cardiovascular, orthopedic, oncology, dental, cosmetic, fertility, ophthalmic, and other specialized treatments, along with bundled care pathways that combine treatment with accommodation, local transport, and post-procedure recovery support when offered as part of organized medical travel services. Services delivered by public and private healthcare providers, as well as bookings facilitated through hospital international patient desks, medical travel facilitators, and digital platforms, are included. Geographic coverage spans international patient inflows from North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa to treatment destinations within India.
The market excludes domestic healthcare consumption by Indian residents, inbound leisure tourism not linked to medical treatment, and long-term migration-related healthcare services. Revenues from pharmaceutical sales unrelated to treatment delivery, medical device manufacturing, hospital infrastructure development, insurance premiums, standalone travel insurance, foreign exchange services, and general travel services not bundled with medical care are excluded. Medical services delivered solely for domestic patients without international travel involvement are outside the defined market scope.
| Items | Values |
|---|---|
| Quantitative Units (2026) | USD 20.4 Billion |
| Treatment Type | Cardiovascular Treatment; Orthopedic Treatment; Oncology Treatment; Cosmetic Treatment; Dental Treatment; Infertility Treatment; Ophthalmic Treatment; Others |
| Age Group | Less Than 15 Years; 15 to 25 Years; 26 to 35 Years; 36 to 45 Years; 46 to 55 Years; Over 55 Years |
| Tourist Type | International |
| Service Provider | Public Provider; Private Provider |
| Traveler Type | Independent Traveler; Package Traveler; Tour Group |
| Demography | Men; Women; Children |
| Booking Channel | Online Booking; In-Person Booking (Hospitals & Facilitators); Phone Booking |
| Regions Covered | West India; South India; East India; North India |
| Countries Covered | India |
| Key Companies Profiled | Apollo Hospitals; Fortis Healthcare; Medanta - The Medicity; Manipal Hospitals; Max Healthcare; Narayana Health; Artemis Hospital |
| Additional Attributes | Dollar spending by treatment type, service provider, and source region; inbound patient flow analysis by country of origin; procedure mix across tertiary and quaternary care; adoption of bundled treatment and recovery packages; length of stay and per-patient spending patterns; competitive positioning of multi-specialty hospital networks and specialty care providers |
Source: FMI historical analysis and forecast data
What is the current market size of India’s medical tourism industry?
India’s medical tourism market is valued at USD 20.4 billion in 2026, supported by rising international patient inflows and strong private hospital capacity.
What is the projected growth rate for India’s medical tourism market?
The market is forecasted to expand at a 12.3% CAGR from 2026 to 2036, reaching USD 65.1 billion by 2036.
Which treatment category dominates the market?
Cardiovascular treatments lead with a 31.6% revenue share, driven by high-value cardiac procedures.
What are the main barriers to growth?
Key barriers include visa processing delays, post-treatment follow-up challenges, and uneven awareness of accredited hospitals.
Who are the leading players in the market?
Major providers include Apollo Hospitals, Fortis Healthcare, Medanta - The Medicity, Manipal Hospitals, Max Healthcare, and Narayana Health.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
India Medical Tourism Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
